The dual role of tetraspanin CD63 in HIV-1 replication

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Li, Guangyu ^a   Endsley, Mark A ^a   Somasunderam, Anoma ^a   Gbota, Sonia L ^a   Mbaka, Maryann I ^a   Murray, James L ^b   Ferguson, Monique R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b GeneTAG Technology Inc   (United States)

Author keywords

HIV 1 replication cycle; Macrophages; Tetraspanin CD63

Indexed keywords

CD4 ANTIGEN; CD63 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; SMALL INTERFERING RNA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL IMMORTALIZATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN PNL4 3); MACROPHAGE; MULTIVESICULAR BODY; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS 1; VESICULAR STOMATITIS VIRUS;

ANTIGENS, CD63; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; TETRASPANINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84893644006     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-23     Document Type: Article

References (40)

1. From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Borner K, Hermle J, Sommer C, Brown NP, Knapp B, Glass B, Kunkel J, Torralba G, Reymann J, Beil N, Beneke J, Pepperkok R, Schneider R, Ludwig T, Hausmann M, Hamprecht F, Erfle H, Kaderali L, Krausslich HG, Lehmann MJ, Biotechnol J 2010 5 1 39 49 10.1002/biot.200900226 20013946
2. Identification of host proteins required for HIV infection through a functional genomic screen. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ, Science 2008 319 5865 921 926 10.1126/science.1152725 18187620
3. Host hindrance to HIV-1 replication in monocytes and macrophages. Bergamaschi A, Pancino G, Retrovirology 2010 7 31 10.1186/1742-4690-7-31 20374633
4. Host cell factors in HIV replication: meta-analysis of genome-wide studies. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, Konig R, Bandyopadhyay S, Ideker T, Goff SP, Krogan NJ, Frankel AD, Young JA, Chanda SK, PLoS Pathog 2009 5 5 1000437 10.1371/journal.ppat.1000437 19478882
5. Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1. Dziuba N, Ferguson MR, O'Brien WA, Sanchez A, Prussia AJ, McDonald NJ, Friedrich BM, Li G, Shaw MW, Sheng J, Hodge TW, Rubin DH, Murray JL, AIDS Res Hum Retroviruses 2012 28 1329 1339 10.1089/aid.2011.0358 22404213
6. Host factors mediating HIV-1 Replication. Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, Ferguson MR, Virus Res 2011 161 101 114 10.1016/j.virusres.2011.08.001 21871504
7. Global landscape of HIV-human protein complexes. Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, Hernandez H, Jang GM, Roth SL, Akiva E, Marlett J, Stephens M, D'Orso I, Fernandes J, Fahey M, Mahon C, O'Donoghue AJ, Todorovic A, Morris JH, Maltby DA, Alber T, Cagney G, Bushman FD, Young JA, Chanda SK, Sundquist WI, Kortemme T, Hernandez RD, Craik CS, Burlingame A, Sali A, Frankel AD, Krogan NJ, Nature 2012 481 7381 365 370
8. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK, Cell 2008 135 1 49 60 10.1016/j.cell.2008.07.032 18854154
9. A whole genome screen for HIV restriction factors. Liu L, Oliveira NM, Cheney KM, Pade C, Dreja H, Bergin AM, Borgdorff V, Beach DH, Bishop CL, Dittmar MT, McKnight A, Retrovirology 2011 8 94 10.1186/1742-4690-8-94 22082156
10. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. Yeung ML, Houzet L, Yedavalli VS, Jeang KT, J Biol Chem 2009 284 29 19463 19473 10.1074/jbc.M109. 010033 19460752
11. Genome-scale RNAi screen for host factors required for HIV replication. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS, Cell Host Microbe 2008 4 5 495 504 10.1016/j.chom.2008.10.004 18976975
12. Functional domains in tetraspanin proteins. Stipp CS, Kolesnikova TV, Hemler ME, Trends Biochem Sci 2003 28 2 106 112 10.1016/S0968-0004(02)00014-2 12575999
13. Tetraspanin functions and associated microdomains. Hemler ME, Nat Rev Mol Cell Biol 2005 6 10 801 811 10.1038/nrm1736 16314869
14. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. Nydegger S, Khurana S, Krementsov DN, Foti M, Thali M, J Cell Biol 2006 173 5 795 807 10.1083/jcb.200508165 16735575
15. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE, J Virol 2006 80 18 9039 9052 10.1128/JVI.01013-06 16940516
16. Infectious HIV-1 assembles in late endosomes in primary macrophages. Pelchen-Matthews A, Kramer B, Marsh M, J Cell Biol 2003 162 3 443 455 10.1083/jcb.200304008 12885763
17. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, Koyanagi Y, J Virol 2008 82 2 1021 1033 10.1128/JVI.01044-07 17989173
18. Human macrophages accumulate HIV-1 particles in MHC II compartments. Raposo G, Moore M, Innes D, Leijendekker R, Leigh-Brown A, Benaroch P, Geuze H, Traffic 2002 3 10 718 729 10.1034/j.1600-0854.2002.31004.x 12230470
19. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. Grigorov B, Arcanger F, Roingeard P, Darlix JL, Muriaux D, J Mol Biol 2006 359 4 848 862 10.1016/j.jmb.2006.04.017 16682056
20. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. Jolly C, Sattentau QJ, J Virol 2007 81 15 7873 7884 10.1128/JVI.01845-06 17522207
21. Identification of an intracellular trafficking and assembly pathway for HIV-1 gag. Perlman M, Resh MD, Traffic 2006 7 6 731 745 10.1111/j.1398-9219. 2006.00428.x 16683918
22. A CD63 mutant inhibits T-cell tropic human immunodeficiency virus type 1 entry by disrupting CXCR4 trafficking to the plasma membrane. Yoshida T, Kawano Y, Sato K, Ando Y, Aoki J, Miura Y, Komano J, Tanaka Y, Koyanagi Y, Traffic 2008 9 4 540 558 10.1111/j.1600-0854.2007.00700.x 18182005
23. N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Yoshida T, Ebina H, Koyanagi Y, Microbiol Immunol 2009 53 11 629 635 10.1111/j.1348-0421.2009.00167.x 19903263
24. CXCR4 expression on activated B cells is downregulated by CD63 and IL-21. Yoshida N, Kitayama D, Arima M, Sakamoto A, Inamine A, Watanabe-Takano H, Hatano M, Koike T, Tokuhisa T, J Immunol 2011 186 5 2800 2808 10.4049/jimmunol.1003401 21270405
25. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. Von Lindern JJ, Rojo D, Grovit-Ferbas K, Yeramian C, Deng C, Herbein G, Ferguson MR, Pappas TC, Decker JM, Singh A, Collman RG, O'Brien WA, J Virol 2003 77 6 3624 3633 10.1128/JVI.77.6.3624-3633. 2003 12610138
26. A critical role for CD63 in HIV replication and infection of macrophages and cell lines. Chen H, Dziuba N, Friedrich B, Von Lindern J, Murray JL, Rojo DR, Hodge TW, O'Brien WA, Ferguson MR, Virology 2008 379 2 191 196 10.1016/j.virol.2008.06.029 18682304
27. A post-entry role for CD63 in early HIV-1 replication. Li G, Dziuba N, Friedrich B, Murray JL, Ferguson MR, Virology 2011 412 2 315 324 10.1016/j.virol.2011.01.017 21315401
28. CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages. Ruiz-Mateos E, Pelchen-Matthews A, Deneka M, Marsh M, J Virol 2008 82 10 4751 4761 10.1128/JVI.02320-07 18321974
29. Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells. Parthasarathy V, Martin F, Higginbottom A, Murray H, Moseley GW, Read RC, Mal G, Hulme R, Monk PN, Partridge LJ, Immunology 2009 127 2 237 248 10.1111/j.1365-2567.2008.02945.x 19489128
30. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. Murray JL, Mavrakis M, McDonald NJ, Yilla M, Sheng J, Bellini WJ, Zhao L, Le Doux JM, Shaw MW, Luo CC, Lippincott-Schwartz J, Sanchez A, Rubin DH, Hodge TW, J Virol 2005 79 18 11742 11751 10.1128/JVI.79.18.11742-11751.2005 16140752
31. A Functional Role for ADAM10 in Human Immunodeficiency Virus Type-1 Replication. Friedrich BM, Murray JL, Li G, Sheng J, Hodge TW, Rubin DH, O'Brien WA, Ferguson MR, Retrovirology 2011 8 32 10.1186/1742-4690-8-32 21569301
32. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, Rabson A, Daugherty D, Gendelman HE, Hoggan MD, Venkatesan S, Martin MA, J Exp Med 1986 164 1 280 290 10.1084/jem.164.1.280 3014036
33. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, Fauci AS, Science 1988 242 4880 919 922 10.1126/science.2460922 2460922
34. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. Goff A, Ehrlich LS, Cohen SN, Carter CA, J Virol 2003 77 17 9173 9182 10.1128/JVI.77.17.9173-9182.2003 12915533
35. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. Ho SH, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN, J Virol 2006 80 13 6487 6496 10.1128/JVI.02539-05 16775336
36. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ, J Cell Biol 2006 172 6 923 935 10.1083/jcb.200508014 16533950
37. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. Nguyen DG, Booth A, Gould SJ, Hildreth JE, J Biol Chem 2003 278 52 52347 52354 10.1074/jbc.M309009200 14561735
38. HIV-1 egress is gated through late endosomal membranes. Nydegger S, Foti M, Derdowski A, Spearman P, Thali M, Traffic 2003 4 12 902 910 10.1046/j.1600-0854.2003.00145.x 14617353
39. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Obrien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, Idler K, Zack JA, Chen IS, Nature 1990 348 6296 69 73 10.1038/348069a0 2172833
40. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, Nathanson N, Srinivasan A, J Virol 1992 66 12 7517 7521 1433527